Jean‐Luc Vanderheyden

Statistics

Publications

Citations

1.5K

H-Index

Active since

1982

Affiliations

University of Massachusetts Chan Medical School(Current)

Stanford University

Uppsala University

Maastricht University Medical Centre

Memorial Sloan Kettering Cancer Center

Jean‐Luc Vanderheyden is an author at University of Massachusetts Chan Medical School specializing in medicine, nuclear medicine, and annexin v imaging.

ORCID

Publications per year

1982–2025

Publications

The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine

Edward Deutsch, Karen Libson, Jean‐Luc Vanderheyden et al. · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · 1986 · 174 citations

Medicine, Chemistry, Nuclear Medicine +12

Quantitative Tumor Apoptosis Imaging Using Technetium-99m–HYNIC Annexin V Single Photon Emission Computed Tomography

Christophe Van de Wiele, Christophe Lahorte, Hubert Vermeersch et al. · Journal of Clinical Oncology · 2003 · 122 citations

Medicine, Oncology, Radiology +16

Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.

Hazel B. Breitz, Paul L. Weiden, Jean‐Luc Vanderheyden et al. · PubMed · 1992 · 119 citations

Medicine, Nuclear Medicine, Oncology +17

Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.

Gerrit J. Kemerink, Xuan Liu, Davy Kieffer et al. · PubMed · 2003 · 117 citations

Medicine, Nuclear Medicine, Radiology +15

Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats.

Roelof J. Bennink, Maurice J.B. van den Hoff, Formijn J. van Hemert et al. · PubMed · 2004 · 85 citations

Medicine, Nuclear Medicine, Pharmacology +13

1–5 of 37